Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.

Kohli R, Lo Y, Howard AA, Buono D, Floris-Moore M, Klein RS, Schoenbaum EE.

Clin Infect Dis. 2005 Sep 15;41(6):864-72. Epub 2005 Aug 16.

PMID:
16107987
2.
3.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, de Wolf F, Fätkenheuer G, Staszewski S, d'Arminio Monforte A, Egger M; Antiretroviral Therapy (ART) Cohort Collaboration.

Lancet. 2006 Aug 5;368(9534):451-8. Review.

PMID:
16890831
4.

Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era.

Crum-Cianflone NF, Weekes J, Bavaro M.

AIDS Patient Care STDS. 2008 Oct;22(10):771-8. doi: 10.1089/apc.2008.0010. Review.

5.

Effect of cigarette smoking on HIV acquisition, progression, and mortality.

Marshall MM, McCormack MC, Kirk GD.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):28-39. doi: 10.1521/aeap.2009.21.3_supp.28. Review.

6.

Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis.

Kufa T, Mabuto T, Muchiri E, Charalambous S, Rosillon D, Churchyard G, Harris RC.

PLoS One. 2014 Nov 13;9(11):e111209. doi: 10.1371/journal.pone.0111209. eCollection 2014. Review.

7.

Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.

Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E.

Public Health. 2016 Oct;139:3-12. doi: 10.1016/j.puhe.2016.05.004. Epub 2016 Jun 24. Review.

PMID:
27349729
8.

Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Degenhardt L, Hall W, Warner-Smith M.

Sex Transm Infect. 2006 Jun;82 Suppl 3:iii56-63. Review.

9.

Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review.

Castilho JL, Melekhin VV, Sterling TR.

AIDS Res Hum Retroviruses. 2014 May;30(5):446-56. doi: 10.1089/AID.2013.0208. Epub 2014 Feb 7. Review.

10.

Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.

Moore RD.

Semin Hematol. 2000 Oct;37(4 Suppl 6):18-23. Review.

PMID:
11068952
11.

Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.

Lake JE, Stanley TL, Apovian CM, Bhasin S, Brown TT, Capeau J, Currier JS, Dube MP, Falutz J, Grinspoon SK, Guaraldi G, Martinez E, McComsey GA, Sattler FR, Erlandson KM.

Clin Infect Dis. 2017 May 15;64(10):1422-1429. doi: 10.1093/cid/cix178. Review.

PMID:
28329372
12.

HIV infection.

Deeks SG, Overbaugh J, Phillips A, Buchbinder S.

Nat Rev Dis Primers. 2015 Oct 1;1:15035. doi: 10.1038/nrdp.2015.35. Review.

PMID:
27188527
13.

Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review.

Milloy MJ, Marshall BD, Kerr T, Buxton J, Rhodes T, Montaner J, Wood E.

AIDS. 2012 Jun 1;26(9):1049-63. doi: 10.1097/QAD.0b013e32835221cc. Review.

14.

Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.

Hunt PW, Lee SA, Siedner MJ.

J Infect Dis. 2016 Oct 1;214 Suppl 2:S44-50. doi: 10.1093/infdis/jiw275. Review.

15.

Factors Associated With Hospitalizations Among HIV-Infected Adults in the United States: Review of the Literature.

Price V, Swanson B, Phillips J, Swartwout K, Fog L, Jegier B.

West J Nurs Res. 2016 Jan;38(1):79-95. doi: 10.1177/0193945914546202. Epub 2014 Aug 10. Review.

PMID:
25112486
16.

Mortality among people who inject drugs: a systematic review and meta-analysis.

Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M.

Bull World Health Organ. 2013 Feb 1;91(2):102-23. doi: 10.2471/BLT.12.108282. Review.

17.

Acute coronary syndromes in patients with HIV.

Seecheran VK, Giddings SL, Seecheran NA.

Coron Artery Dis. 2017 Mar;28(2):166-172. doi: 10.1097/MCA.0000000000000450. Review.

18.

Multimorbidity and Burden of Disease.

Brown TT, Guaraldi G.

Interdiscip Top Gerontol Geriatr. 2017;42:59-73. Epub 2016 Nov 22. Review.

PMID:
27875824
19.

Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons.

Petoumenos K, Law MG.

Curr Opin HIV AIDS. 2016 Sep;11(5):514-520. Review.

PMID:
27327615
20.

A review of the study designs and statistical methods used in the determination of predictors of all-cause mortality in HIV-infected cohorts: 2002-2011.

Otwombe KN, Petzold M, Martinson N, Chirwa T.

PLoS One. 2014 Feb 3;9(2):e87356. doi: 10.1371/journal.pone.0087356. eCollection 2014. Review.

Supplemental Content

Support Center